Ebro Foods SA
MAD:EBRO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.7
18.6537
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Ebro Foods SA
Ebro Foods SA, a Spanish multinational with a storied history, stands as a significant player in the global food sector. The company's journey began with a focus on sugar production, but strategic diversification and a keen eye on shifting market demands steered its evolution toward becoming the world's leading rice and the second-largest pasta company. At its core, Ebro Foods thrives by targeting staple food products that remain consistently in demand worldwide. The company operates through a range of trusted brands like Riviana, Tilda, and Garofalo, which hold strong footholds in different regions, thus allowing Ebro Foods to garner a diversified revenue stream across international markets.
Ebro Foods' business model hinges on its extensive value chain, encompassing everything from sourcing raw materials to producing and marketing finished food products. This comprehensive approach ensures quality control across the board, enabling the company to enhance its competitive edge through innovation and efficiency. Ebro Foods invests considerably in R&D, driving product diversification that meets evolving consumer tastes, including organic and gluten-free alternatives. Its robust logistics network ensures a seamless flow of products to retail and institutional customers, amplified by savvy marketing strategies that nurture brand loyalty. Through this multifaceted operation, Ebro Foods generates profit by selling essential everyday products—a model that ensures stability and resilience amid economic fluctuations.
Ebro Foods SA, a Spanish multinational with a storied history, stands as a significant player in the global food sector. The company's journey began with a focus on sugar production, but strategic diversification and a keen eye on shifting market demands steered its evolution toward becoming the world's leading rice and the second-largest pasta company. At its core, Ebro Foods thrives by targeting staple food products that remain consistently in demand worldwide. The company operates through a range of trusted brands like Riviana, Tilda, and Garofalo, which hold strong footholds in different regions, thus allowing Ebro Foods to garner a diversified revenue stream across international markets.
Ebro Foods' business model hinges on its extensive value chain, encompassing everything from sourcing raw materials to producing and marketing finished food products. This comprehensive approach ensures quality control across the board, enabling the company to enhance its competitive edge through innovation and efficiency. Ebro Foods invests considerably in R&D, driving product diversification that meets evolving consumer tastes, including organic and gluten-free alternatives. Its robust logistics network ensures a seamless flow of products to retail and institutional customers, amplified by savvy marketing strategies that nurture brand loyalty. Through this multifaceted operation, Ebro Foods generates profit by selling essential everyday products—a model that ensures stability and resilience amid economic fluctuations.
Sales Growth: Group sales increased 7.2% year-on-year to EUR 2,035.2 million in the first nine months, with strong performance in rice and pasta divisions.
Profitability: EBITDA grew 13% to EUR 236 million for the first nine months, and net profit increased by 15.1% to EUR 114.7 million.
Tilda Acquisition: Acquired basmati brand Tilda for $342 million, consolidating leadership in the premium segment and expanding presence in key markets.
Guidance Raised: Year-end sales forecast raised to EUR 2,784.6 million, with targeted EBITDA growth of 11% to EUR 340.6 million and net profit expected to rise 12.4% to EUR 159 million.
Operational Improvements: U.S. plant issues have been addressed with organizational changes, leading to improved productivity, though not yet at 2017 all-time highs.
Debt Levels: Net debt increased due to acquisitions, but management is comfortable with the near 3x net debt-to-EBITDA ratio, citing low-interest rates.